Structures by: Poojary B.
Total: 14
Ethyl 1-benzyl-2-(3-chlorophenyl)-1<i>H</i>-benzimidazole-5-carboxylate
C23H19ClN2O2
IUCrData (2016) 1, 7 x161068
a=11.145(3)Å b=9.878(2)Å c=18.355(4)Å
α=90° β=93.952(7)° γ=90°
Ethyl 2-(3,5-difluorophenyl)quinoline-4-carboxylate
C18H13F2NO2
IUCrData (2016) 1, 5 x160739
a=8.9998(8)Å b=9.0314(6)Å c=10.2747(5)Å
α=67.15(2)° β=72.45(3)° γ=82.91(3)°
1-Chloro-4-(3,4-dichlorophenyl)-3,4-dihydronaphthalene-2-carbaldehyde
C17H11Cl3O
Acta Crystallographica Section E (2011) 67, 2 o378
a=10.2969(5)Å b=10.8849(5)Å c=13.6144(7)Å
α=90.00° β=91.436(5)° γ=90.00°
2-[4-(Methylsulfonyl)phenyl]acetonitrile
C9H9NO2S
Acta Crystallographica Section E (2011) 67, 3 o574
a=5.5599(2)Å b=8.0942(3)Å c=10.9006(4)Å
α=81.162(2)° β=85.347(2)° γ=74.458(2)°
Methyl 2-[2-(benzyloxycarbonylamino)propan-2-yl]-5-hydroxy-6-methoxypyrimidine-4-carboxylate
C18H21N3O6
Acta Crystallographica Section E (2011) 67, 2 o274
a=16.5226(2)Å b=8.57170(10)Å c=13.0944(2)Å
α=90.00° β=97.2360(10)° γ=90.00°
Benzyl <i>N</i>-{2-[5-(4-chlorophenyl)-1,2,4-oxadiazol-3-yl]propan-2-yl}carbamate
C19H18ClN3O3
Acta Crystallographica Section E (2011) 67, 2 o420-o421
a=7.75010(10)Å b=11.0052(2)Å c=20.9834(3)Å
α=90.00° β=90.00° γ=90.00°
1-{4-Chloro-2-[2-(2-fluorophenyl)-1,3-dithiolan-2-yl]phenyl}-2-methyl-1<i>H</i>-imidazole-5-carbaldehyde
C20H16ClFN2OS2
Acta Crystallographica Section E (2011) 67, 2 o496-o497
a=18.5654(3)Å b=9.27300(10)Å c=24.7174(4)Å
α=90.00° β=116.8070(10)° γ=90.00°
<i>N</i>'-(4-Fluorobenzylidene)-2-(4-fluorophenyl)acetohydrazide
C15H12F2N2O
Acta Crystallographica Section E (2011) 67, 11 o2835
a=13.8754(15)Å b=12.5349(13)Å c=7.7093(8)Å
α=90.00° β=93.566(2)° γ=90.00°
<i>N</i>'-(4-Chlorobenzylidene)-2-[4-(methylsulfanyl)phenyl]acetohydrazide
C16H15ClN2OS
Acta Crystallographica Section E (2011) 67, 11 o2847
a=17.0923(13)Å b=9.6719(7)Å c=9.5592(7)Å
α=90.00° β=92.3990(10)° γ=90.00°
(5<i>E</i>)-5-(2,4-Dichlorobenzylidene)-2-(piperidin-1-yl)- 1,3-thiazol-4(5<i>H</i>)-one
C15H14Cl2N2OS
Acta Crystallographica Section E (2011) 67, 11 o2884
a=28.5303(3)Å b=7.49150(10)Å c=15.4789(2)Å
α=90.00° β=116.4070(10)° γ=90.00°
3-{1-[4-(2-Methylpropyl)phenyl]ethyl}-4-phenyl-1<i>H</i>- 1,2,4-triazole-5(4<i>H</i>)-thione
C20H23N3S
Acta Crystallographica Section E (2011) 67, 8 o1943
a=6.3249(2)Å b=12.4958(5)Å c=12.9125(4)Å
α=77.6490(10)° β=78.1330(10)° γ=76.5510(10)°
(5<i>E</i>)-5-(4-Methoxybenzylidene)-2-(piperidin-1-yl)-1,3-thiazol- 4(5<i>H</i>)-one
C16H18N2O2S
Acta Crystallographica Section E (2011) 67, 8 o1915
a=8.5811(3)Å b=16.5165(6)Å c=12.4930(4)Å
α=90.00° β=121.518(2)° γ=90.00°
<i>N</i>-(2-Chlorophenyl)-2-({5-[4-(methylsulfanyl)benzyl]-4-phenyl-4<i>H</i>- 1,2,4-triazol-3-yl}sulfanyl)acetamide
C24H21ClN4OS2
Acta Crystallographica Section E (2011) 67, 8 o2063
a=14.2542(7)Å b=16.3273(9)Å c=10.1584(6)Å
α=90.00° β=96.3720(10)° γ=90.00°